玛凯纳的“天外来神”？ - Suppr

Deus ex Makena?

作者信息

Silver Robert M, Cunningham F Gary

机构信息

Dr. Silver is from the University of Utah Health Sciences Center, Department of Obstetrics and Gynecology, Salt Lake City, Utah; e-mail:

出版信息

Obstet Gynecol. 2011 Jun;117(6):1263-1265. doi: 10.1097/AOG.0b013e31821c6fb1.

DOI:10.1097/AOG.0b013e31821c6fb1

PMID:21471852

Abstract

摘要

相似文献

Deus ex Makena?

Obstet Gynecol. 2011 Jun;117(6):1263-1265. doi: 10.1097/AOG.0b013e31821c6fb1.

Deus ex Makena?

Obstet Gynecol. 2011 Oct;118(4):955; author reply 955-6. doi: 10.1097/AOG.0b013e31822f8774.

17 α-hydroxyprogesterone caproate (Makena®): a guide to its use in the prevention of preterm birth.

Clin Drug Investig. 2013 Mar;33(3):223-7. doi: 10.1007/s40261-013-0060-6.

Unjustified increase in cost of care resulting from U.S. Food and Drug Administration approval of Makena (17α-hydroxyprogesterone caproate).

Obstet Gynecol. 2011 Jun;117(6):1408-1412. doi: 10.1097/AOG.0b013e31821c2d75.

Progesterone is not the same as 17α-hydroxyprogesterone caproate: implications for obstetrical practice.

Am J Obstet Gynecol. 2013 Jun;208(6):421-6. doi: 10.1016/j.ajog.2013.04.027. Epub 2013 Apr 30.

Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.

Am J Obstet Gynecol. 2016 Jan;214(1):45-56. doi: 10.1016/j.ajog.2015.10.934. Epub 2015 Nov 10.

Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy.

Eur J Obstet Gynecol Reprod Biol. 2017 Sep;216:164-168. doi: 10.1016/j.ejogrb.2017.06.004. Epub 2017 Jun 3.

17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?

Semin Perinatol. 2017 Dec;41(8):461-467. doi: 10.1053/j.semperi.2017.08.004. Epub 2017 Sep 22.

Society for Maternal-Fetal Medicine Statement: Response to the Food and Drug Administration's withdrawal of 17-alpha hydroxyprogesterone caproate.

Am J Obstet Gynecol. 2023 Jul;229(1):B2-B6. doi: 10.1016/j.ajog.2023.04.012. Epub 2023 Apr 13.

The association between 17-hydroxyprogesterone caproate use and postpartum hemorrhage.

Am J Obstet Gynecol MFM. 2019 May;1(2):144-147. doi: 10.1016/j.ajogmf.2019.04.004. Epub 2019 Apr 28.

引用本文的文献

Challenges in Using Progestin to Prevent Singleton Preterm Births: Current Knowledge and Clinical Advice.

Int J Womens Health. 2024 Jan 22;16:119-130. doi: 10.2147/IJWH.S394305. eCollection 2024.

Ameliorating adverse perinatal outcomes with Lactoferrin: An intriguing chemotherapeutic intervention.

Bioorg Med Chem. 2022 Nov 15;74:117037. doi: 10.1016/j.bmc.2022.117037. Epub 2022 Sep 29.

Next generation strategies for preventing preterm birth.

Adv Drug Deliv Rev. 2021 Jul;174:190-209. doi: 10.1016/j.addr.2021.04.021. Epub 2021 Apr 23.

Enhanced drug delivery to the reproductive tract using nanomedicine reveals therapeutic options for prevention of preterm birth.

Sci Transl Med. 2021 Jan 13;13(576). doi: 10.1126/scitranslmed.abc6245.

Development of a mucoinert progesterone nanosuspension for safer and more effective prevention of preterm birth.

J Control Release. 2019 Feb 10;295:74-86. doi: 10.1016/j.jconrel.2018.12.046. Epub 2018 Dec 28.

Progesterone supplementation and the prevention of preterm birth.

Rev Obstet Gynecol. 2011 Summer;4(2):60-72.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Deus ex Makena?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献